ILMN Jan 2024 380.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:46PM EST. Market open.
Loading interactive chart…
- Zacks
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for
Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Financial Times
Has Illumina taken the wrong path in its Grail quest?
DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators
© 2023 Yahoo. All rights reserved.
